Reduction of discomfort associated with menopauseThe effectiveness of Lifenol® has been demonstrated in clinical trials conducted with menopausal women The effectiveness of Lifenol® in relieving discomfort associated with menopause has been assessed in a randomised, double-blind and placebo-controlled study published in the scientific journal Maturitas. The evolution of symptoms was measured via a questionnaire filled-in by doctors monitoring the women taking supplements: the Kupperman index (for more information). This test took into account hot flashes, sleeping disorders, irritability, headaches, etc. After 6 weeks taking Lifenol® supplements, at the recommended dose of 100µg of 8-prenylnaringenin a day, we observed a significant reduction in symptoms associated with menopause, compared to the placebo.
|
|
* Clinical results obtained after taking Lifenol® supplements providing 100µg of 8-prenylnaringenin a day for 6 weeks. |
